MDCE AI Vision Platform Update
Analysis based on 6 articles · First reported Jul 28, 2026 · Last updated Jul 28, 2026
The announcement is a minor positive for MDCE's stock, signaling technological progress but with no immediate revenue impact. The market attention is low given the company's OTC listing and early-stage technology.
Medical Care Technologies Inc. (OTC PINK:MDCE) announced on July 28, 2026, that its AI vision platform has advanced beyond the scope of its earlier provisional patent application (No. 63/854,935), leading the company to abandon further prosecution of that application. The company has shifted focus to continuously learning AI models for enterprise-level visual identification, quality control, and imaging analysis, targeting healthcare, agriculture, and industrial sectors. CEO Marshall Perkins highlighted the platform's expanded relevance.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard